Kevin F. Gibson

This study tested whether the drug maraviroc could reduce harmful inflammation in the lungs of people with active sarcoidosis. Three participants took maraviroc for six weeks. Researchers compared immune cells from lung washings before and after treatment to see if the drug chang…